← Strata Critical Medical, Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31.2m |
$23.4m
-24.88%
|
$50.5m
+115.61%
|
$146.1m
+189.20%
|
$225.2m
+54.11%
|
$248.7m
+10.44%
|
$197.1m
-20.73%
|
$256.0m
+29.84%
|
|
| Realized loss from sales of short-term investments | — | — | $0 | ($2.2m) | $8k | $0 | ($5.2m) | — | |
| Cost of revenue | $26.5m |
$21.1m
-20.34%
|
$39.7m
+88.19%
|
$123.8m
+211.79%
|
$183.1m
+47.81%
|
$189.8m
+3.67%
|
$156.0m
-17.79%
|
$201.6m
+29.20%
|
|
| Gross Profit | $4.7m |
$2.3m
-50.48%
|
$10.8m
+364.33%
|
$22.3m
+106.15%
|
$42.1m
+89.10%
|
$29.6m
-29.75%
|
$41.1m
+38.99%
|
$54.4m
+32.27%
|
|
| Selling, general and administrative | — | — | — | — | — | $50.9m | $60.9m | $64.1m | |
| Amortization of intangible assets | — | — | — | — | — | $1.3m | $2.6m | — | |
| Total operating expenses | $42.7m | $678k | $74.6m | $199.6m | $293.3m | $282.6m | $63.5m | $74.8m | |
| Operating loss from continuing operations | ($11.5m) | ($678k) | ($24.1m) | ($53.5m) | ($68.1m) | ($33.9m) | ($22.4m) | — | |
| Interest income | — | — | — | — | $8.4m | $7.2m | $4.2m | $2.6m | |
| Total other non-operating income | $703k | $199k | ($19.6m) | $25.5m | $10.6m | $6.4m | $2.3m | — | |
| Loss from continuing operations before income taxes | ($10.8m) | $338k | ($43.7m) | ($28.0m) | ($57.5m) | ($27.6m) | ($20.1m) | — | |
| Income tax expense from continuing operations | ($209k) | ($210k) | ($3.6m) | ($772k) | ($1.5m) | ($255k) | $0 | $0 | |
| Net loss from continuing operations | — | — | — | — | — | ($16.2m) | ($20.1m) | — | |
| Net income (loss) from discontinued operations | — | — | — | — | — | ($11.1m) | $61.4m | $40.2m | |
| Net income (loss) | ($10.8m) |
$128k
+101.18%
|
($40.1m)
-31459.71%
|
($27.3m)
+31.94%
|
($56.1m)
-105.71%
|
($27.3m)
+51.30%
|
$41.3m
+251.42%
|
$40.2m
-2.72%
|
|
| Continuing operations, basic (in dollars per share) | — | — | — | — | — | ($0.21) | ($0.24) | — | |
| Continuing operations , diluted (in dollars per share) | — | — | — | — | — | ($0.21) | ($0.24) | — | |
| Discontinued operations, basic (in dollars per share) | — | — | — | — | — | ($0.14) | $0.75 | — | |
| Discontinued operations, diluted (in dollars per share) | — | — | — | — | — | ($0.14) | $0.75 | — | |
| Total basic earnings (loss) per share (in dollars per share) | ($0.43) | ($0.40) | ($0.93) | ($0.38) | ($0.76) | ($0.35) | $0.50 | — | |
| Total diluted earnings (loss) per share (in dollars per share) | ($0.43) | ($0.40) | ($0.93) | ($0.38) | ($0.76) | ($0.35) | $0.50 | — | |
| Basic (in shares) | $25.1m | $25.2m | $42.9m | $71.2m | $73.5m | $77.5m | $82.1m | $84.7m | |
| Diluted (in shares) | $25.1m | $25.2m | $42.9m | $71.2m | $73.5m | $77.5m | $82.1m | $84.7m | |
| Change in fair value of warrant liabilities | $0 | $0 | ($18.3m) | $24.2m | $2.1m | ($850k) | $4.3m | — | |
| Change in fair value of assets and other liabilities | — | — | — | — | — | $0 | ($1.0m) | — |